Imaging of Unstable Carotid Plaque in Patient Referred to Endarterectomy
NCT03353103 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-01-13
Summary
This study will assess unstable plaque imaging features by using high resolution MR imaging and Sodium Fluoride F-18 PET. This is a comparative study between symptomatic and asymptomatic patient referred to carotid endateriectomy, with reference to pathologic analysis of plaque components
Conditions
- Carotid Artery Stenosis
Interventions
- DRUG
-
Sodium fluoride F-18 PET imaging
prior to surgical endarterectomy each patient will undergo sodium fluoride F-18 PET imaging
Sponsors & Collaborators
-
University Hospital, Caen
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-03
- Primary Completion
- 2020-06-30
- Completion
- 2021-06-30
Countries
- France
Study Locations
More Related Trials
-
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis
NCT02417688 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
NCT01992380 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
NCT01053312 ·Status: COMPLETED ·Phase: PHASE3
-
18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study
NCT02556502 ·Status: COMPLETED ·Phase: NA
-
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
NCT02813434 ·Status: UNKNOWN ·Phase: PHASE3
-
PET Tau - Neurodegenerative Disease Imaging
NCT03143374 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
NCT03080051 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Isotopic Imaging for Prodromal Alzheimer's Disease
NCT01231295 ·Status: COMPLETED
-
18F-Flutemetamol and Plaque Vulnerability
NCT03291093 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.
NCT03514524 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction
NCT02948140 ·Status: TERMINATED ·Phase: NA
-
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
NCT00547976 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Selective Cerebrovascular Distribution With FDCT in the Angiosuite
NCT03916133 ·Status: COMPLETED ·Phase: NA
-
PET Detection of CCR2 in Human Atherosclerosis
NCT04537403 ·Status: RECRUITING ·Phase: PHASE1
-
Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
NCT01095744 ·Status: COMPLETED
-
Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
NCT01012674 ·Status: COMPLETED ·Phase: PHASE3
-
Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation
NCT00677963 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Sensitivity and Specificity of 3.0 Tesla MRI for Carotid Artery Plaque
NCT01632254 ·Status: UNKNOWN
-
Molecular Imaging of Plaque Vulnerability
NCT02640313 ·Status: RECRUITING ·Phase: PHASE3
-
Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases
NCT06731842 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Tau PET Imaging in the NACC Study Cohort
NCT03189485 ·Status: ACTIVE_NOT_RECRUITING
-
FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD
NCT04311281 ·Status: WITHDRAWN
-
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
NCT02003183 ·Status: COMPLETED
-
Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke
NCT02513589 ·Status: TERMINATED ·Phase: PHASE2
-
A Non-drug Methods Study in Participants With Alzheimer's Disease
NCT01459016 ·Status: COMPLETED ·Phase: PHASE1